Table 2.
Variables | β Coefficient | Multivariate Cox Regression Analysis | |
---|---|---|---|
HR (95% CI) | P Value | ||
Age, per y | 0.077 | 1.080 (1.079–1.080) | <0.001 |
Male sex | 0.232 | 1.261 (1.253–1.268) | <0.001 |
Hypertension | 0.343 | 1.408 (1.398–1.419) | <0.001 |
Diabetes mellitus | 0.082 | 1.086 (1.075–1.096) | <0.001 |
Heart failure | 0.894 | 2.444 (2.413–2.475) | <0.001 |
Prior stroke | 0.127 | 1.136 (1.121–1.151) | <0.001 |
Coronary artery disease | |||
Without MI | 0.377 | 1.457 (1.444–1.471) | <0.001 |
With MI | 0.435 | 1.545 (1.504–1.588) | <0.001 |
Peripheral vascular diseases | −0.038 | 0.963 (0.928–0.999) | 0.042 |
COPD | 0.151 | 1.163 (1.151–1.175) | <0.001 |
Autoimmune diseases | 0.071 | 1.074 (1.047–1.101) | <0.001 |
Liver cirrhosis | 0.139 | 1.149 (1.108–1.191) | <0.001 |
Hyperthyroidism | 0.143 | 1.153 (1.090–1.216) | <0.001 |
CKD | |||
Without ESRD | 0.104 | 1.109 (1.080–1.139) | <0.001 |
With ESRD | 0.375 | 1.454 (1.419–1.490) | <0.001 |
Gout | 0.146 | 1.158 (1.143–1.172) | <0.001 |
Alcoholism | 0.338 | 1.402 (1.342–1.464) | <0.001 |
AF indicates atrial fibrillation; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ESRD, end‐stage renal disease; HR, hazard ratio; and MI, myocardial infarction.